Atlas Trials

Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

Clinical trial NCT07070648 · RECRUITING

Trial details

NCT number
NCT07070648
Sponsor
Fudan University
Status
RECRUITING
Study type
OBSERVATIONAL
Diffuse Large B-Cell LymphomaDLBCL
Start date
2025-05-09
Primary completion
2026-12-30
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.